Does SIMVASTATIN Cause Intentional product use issue? 309 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 309 reports of Intentional product use issue have been filed in association with SIMVASTATIN (Simvastatin). This represents 1.1% of all adverse event reports for SIMVASTATIN.
309
Reports of Intentional product use issue with SIMVASTATIN
1.1%
of all SIMVASTATIN reports
4
Deaths
108
Hospitalizations
How Dangerous Is Intentional product use issue From SIMVASTATIN?
Of the 309 reports, 4 (1.3%) resulted in death, 108 (35.0%) required hospitalization, and 79 (25.6%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 309 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which SIMVASTATIN Alternatives Have Lower Intentional product use issue Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS